BIOMAT Database Logo BIOMAT Database Logo

Irreversible inhibitors of serine, cysteine, and threonine proteases. 2002

James C Powers, and Juliana L Asgian, and Ozlem Dogan Ekici, and Karen Ellis James
School of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, Georgia 30332-0400, USA. James.Powers@chemistry.gatech.edu

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D010450 Endopeptidases A subclass of PEPTIDE HYDROLASES that catalyze the internal cleavage of PEPTIDES or PROTEINS. Endopeptidase,Peptide Peptidohydrolases
D011480 Protease Inhibitors Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES). Antiprotease,Endopeptidase Inhibitor,Endopeptidase Inhibitors,Peptidase Inhibitor,Peptidase Inhibitors,Peptide Hydrolase Inhibitor,Peptide Hydrolase Inhibitors,Peptide Peptidohydrolase Inhibitor,Peptide Peptidohydrolase Inhibitors,Protease Antagonist,Protease Antagonists,Antiproteases,Protease Inhibitor,Antagonist, Protease,Antagonists, Protease,Hydrolase Inhibitor, Peptide,Hydrolase Inhibitors, Peptide,Inhibitor, Endopeptidase,Inhibitor, Peptidase,Inhibitor, Peptide Hydrolase,Inhibitor, Peptide Peptidohydrolase,Inhibitor, Protease,Inhibitors, Endopeptidase,Inhibitors, Peptidase,Inhibitors, Peptide Hydrolase,Inhibitors, Peptide Peptidohydrolase,Inhibitors, Protease,Peptidohydrolase Inhibitor, Peptide,Peptidohydrolase Inhibitors, Peptide
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D015842 Serine Proteinase Inhibitors Exogenous or endogenous compounds which inhibit SERINE ENDOPEPTIDASES. Serine Endopeptidase Inhibitor,Serine Endopeptidase Inhibitors,Serine Protease Inhibitor,Serine Protease Inhibitors,Serine Proteinase Antagonist,Serine Proteinase Antagonists,Serine Proteinase Inhibitor,Serine Proteinase Inhibitors, Endogenous,Serine Proteinase Inhibitors, Exogenous,Serine Protease Inhibitors, Endogenous,Serine Protease Inhibitors, Exogenous,Antagonist, Serine Proteinase,Endopeptidase Inhibitor, Serine,Inhibitor, Serine Endopeptidase,Inhibitor, Serine Protease,Inhibitor, Serine Proteinase,Protease Inhibitor, Serine,Proteinase Antagonist, Serine,Proteinase Inhibitor, Serine

Related Publications

James C Powers, and Juliana L Asgian, and Ozlem Dogan Ekici, and Karen Ellis James
Irreversible inhibitors of cysteine proteases.
February 2013, ACS medicinal chemistry letters,
James C Powers, and Juliana L Asgian, and Ozlem Dogan Ekici, and Karen Ellis James
Peptide aldehydes: potent inhibitors of serine and cysteine proteases.
January 1977, Methods in enzymology,
James C Powers, and Juliana L Asgian, and Ozlem Dogan Ekici, and Karen Ellis James
Peptidyl cyclopropenones: reversible inhibitors, irreversible inhibitors, or substrates of cysteine proteases?
June 2013, Protein science : a publication of the Protein Society,
James C Powers, and Juliana L Asgian, and Ozlem Dogan Ekici, and Karen Ellis James
Plant Serpins: Potential Inhibitors of Serine and Cysteine Proteases with Multiple Functions.
October 2023, Plants (Basel, Switzerland),
James C Powers, and Juliana L Asgian, and Ozlem Dogan Ekici, and Karen Ellis James
A fragment-based method to discover irreversible covalent inhibitors of cysteine proteases.
June 2014, Journal of medicinal chemistry,
James C Powers, and Juliana L Asgian, and Ozlem Dogan Ekici, and Karen Ellis James
Vanadium inhibition of serine and cysteine proteases.
March 1999, Comparative biochemistry and physiology. Part A, Molecular & integrative physiology,
James C Powers, and Juliana L Asgian, and Ozlem Dogan Ekici, and Karen Ellis James
Serine/Threonine Ligation and Cysteine/Penicillamine Ligation.
January 2022, Methods in molecular biology (Clifton, N.J.),
James C Powers, and Juliana L Asgian, and Ozlem Dogan Ekici, and Karen Ellis James
Inhibitors of cysteine proteases.
January 2006, Current topics in medicinal chemistry,
James C Powers, and Juliana L Asgian, and Ozlem Dogan Ekici, and Karen Ellis James
Fragment-Based Discovery of Irreversible Covalent Inhibitors of Cysteine Proteases Using Chlorofluoroacetamide Library.
January 2020, Chemical & pharmaceutical bulletin,
James C Powers, and Juliana L Asgian, and Ozlem Dogan Ekici, and Karen Ellis James
N-Acyl and N-sulfonyloxazolidine-2,4-diones are pseudo-irreversible inhibitors of serine proteases.
June 2012, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!